WEBVTT 99:59:59.999 --> 99:59:59.999 I have a tendency to assume the worst, 99:59:59.999 --> 99:59:59.999 and once in a while, this habit plays tricks on me. 99:59:59.999 --> 99:59:59.999 For example, if I feel unexpected pain in my body 99:59:59.999 --> 99:59:59.999 that I have not experienced before and that I cannot attribute, 99:59:59.999 --> 99:59:59.999 then all of a sudden, my mind my turn a tense back into heart disease 99:59:59.999 --> 99:59:59.999 or calf muscle pain into ??. 99:59:59.999 --> 99:59:59.999 But so far I haven't been diagnosed with any deadly or incurable disease. 99:59:59.999 --> 99:59:59.999 Sometimes things just hurt for no clear reason. 99:59:59.999 --> 99:59:59.999 But not everyone is as lucky as me. 99:59:59.999 --> 99:59:59.999 Every year, more than 50 million people die worldwide. 99:59:59.999 --> 99:59:59.999 Especially in high-income economies like ours, 99:59:59.999 --> 99:59:59.999 a large fraction of deaths is caused by slowly progressing diseases: 99:59:59.999 --> 99:59:59.999 heart disease, chronic lung disease, cancer, Alzheimer's, diabetes, 99:59:59.999 --> 99:59:59.999 just to name a few. 99:59:59.999 --> 99:59:59.999 Now, humanity has made tremendous progress in diagnosing and treating many of these, 99:59:59.999 --> 99:59:59.999 but we are at stage where further advancement in health 99:59:59.999 --> 99:59:59.999 cannot be achieved only by developing new treatments, 99:59:59.999 --> 99:59:59.999 and this becomes evident when we look at one aspect 99:59:59.999 --> 99:59:59.999 that many of these diseases have in common. 99:59:59.999 --> 99:59:59.999 The probability for successful treatment 99:59:59.999 --> 99:59:59.999 strongly depends on when treatment is started, 99:59:59.999 --> 99:59:59.999 but a disease is typically only detected once symptoms occur, 99:59:59.999 --> 99:59:59.999 and the problem here is that in fact many disease can remain asymptomatic, 99:59:59.999 --> 99:59:59.999 hence undetected, for a long period of time. 99:59:59.999 --> 99:59:59.999 Because of this, there is a persisting need for new ways 99:59:59.999 --> 99:59:59.999 of detecting disease at early stage, way before any symptoms occur. 99:59:59.999 --> 99:59:59.999 In health care, this is called screening, 99:59:59.999 --> 99:59:59.999 and as defined by the World Health Organization, 99:59:59.999 --> 99:59:59.999 screening is the presumptive identification 99:59:59.999 --> 99:59:59.999 of unrecognized disease 99:59:59.999 --> 99:59:59.999 in an apparently healthy person 99:59:59.999 --> 99:59:59.999 by means of tests that can be applied rapidly and easily. 99:59:59.999 --> 99:59:59.999 That's a long definition, so let me repeat it: 99:59:59.999 --> 99:59:59.999 identification of unrecognized disease 99:59:59.999 --> 99:59:59.999 in an apparently healthy person 99:59:59.999 --> 99:59:59.999 by means of tests that can be applied both rapidly and easily. 99:59:59.999 --> 99:59:59.999 And I want to put special emphasis on the words "rapidly" and "easily," 99:59:59.999 --> 99:59:59.999 because many of the existing screening methods 99:59:59.999 --> 99:59:59.999 are exactly the opposite. 99:59:59.999 --> 99:59:59.999 And those of you who have gone colonoscopy 99:59:59.999 --> 99:59:59.999 as part of a screening program for colorectal cancer 99:59:59.999 --> 99:59:59.999 will know what I mean. 99:59:59.999 --> 99:59:59.999 Obviously, there's a variety of medical tools available 99:59:59.999 --> 99:59:59.999 to perform screening tests. 99:59:59.999 --> 99:59:59.999 This ranges from imaging techniques 99:59:59.999 --> 99:59:59.999 such as radiography or magnetic resonance imaging 99:59:59.999 --> 99:59:59.999 to the analysis of blood or tissue. 99:59:59.999 --> 99:59:59.999 We have all had such tests. 99:59:59.999 --> 99:59:59.999 But there's one medium that for long has been overlooked, 99:59:59.999 --> 99:59:59.999 a medium that is easily accessible, 99:59:59.999 --> 99:59:59.999 basically non-depletable, 99:59:59.999 --> 99:59:59.999 and it holds tremendous promise for medical analysis, 99:59:59.999 --> 99:59:59.999 and that is our breath. 99:59:59.999 --> 99:59:59.999 Human breath is essentially composed of five components: 99:59:59.999 --> 99:59:59.999 nitrogen, oxygen, carbon dioxide, water and argon, 99:59:59.999 --> 99:59:59.999 but besides these five, there are hundreds of other components 99:59:59.999 --> 99:59:59.999 that are present in very low quantity. 99:59:59.999 --> 99:59:59.999 These are called volatile organic compounds, 99:59:59.999 --> 99:59:59.999 and we release hundreds, even thousands of them, 99:59:59.999 --> 99:59:59.999 every time we exhale. 99:59:59.999 --> 99:59:59.999 The analysis of these volatile organic compounds in our breath 99:59:59.999 --> 99:59:59.999 is called breath analysis. 99:59:59.999 --> 99:59:59.999 In fact, I believe that many of you have already experienced breath analysis. 99:59:59.999 --> 99:59:59.999 Imagine, you're driving home late at night 99:59:59.999 --> 99:59:59.999 when suddenly there's a friendly police officer 99:59:59.999 --> 99:59:59.999 who asks you kindly but firmly 99:59:59.999 --> 99:59:59.999 to pull over and blow into a device like this one. 99:59:59.999 --> 99:59:59.999 This is an alcohol breath tester 99:59:59.999 --> 99:59:59.999 that is used to measure the ethanol concentration in your breath 99:59:59.999 --> 99:59:59.999 and determine whether driving in your condition is a clever idea. 99:59:59.999 --> 99:59:59.999 Now I'd say my driving was pretty good, 99:59:59.999 --> 99:59:59.999 but let me check. 99:59:59.999 --> 99:59:59.999 (Beep) 99:59:59.999 --> 99:59:59.999 0.0, so nothing to worry about, all fine. 99:59:59.999 --> 99:59:59.999 Now, imagine a device like this one 99:59:59.999 --> 99:59:59.999 that does not only measure alcohol levels in your breath, 99:59:59.999 --> 99:59:59.999 but that detects diseases 99:59:59.999 --> 99:59:59.999 like the ones I've shown you and potentially many more. 99:59:59.999 --> 99:59:59.999 The concept of correlating the smell of a person's breath 99:59:59.999 --> 99:59:59.999 with certain medical conditions 99:59:59.999 --> 99:59:59.999 in fact dates back to Ancient Greece, 99:59:59.999 --> 99:59:59.999 but only recently, research efforts on breath analysis have skyrocketed, 99:59:59.999 --> 99:59:59.999 and what once was a dream is now becoming reality. 99:59:59.999 --> 99:59:59.999 And let me pull up this list again that I showed you earlier. 99:59:59.999 --> 99:59:59.999 For the majority of diseases listed here, 99:59:59.999 --> 99:59:59.999 there's substantial scientific evidence suggesting that the disease 99:59:59.999 --> 99:59:59.999 could be detected by breath analysis. 99:59:59.999 --> 99:59:59.999 But how does it work exactly? 99:59:59.999 --> 99:59:59.999 The essential part is a sensor device 99:59:59.999 --> 99:59:59.999 that detects the volatile organic compounds in our breath. 99:59:59.999 --> 99:59:59.999 Simply put, when exposed to a breath sample, 99:59:59.999 --> 99:59:59.999 the sensor outputs a complex signature 99:59:59.999 --> 99:59:59.999 that results from the mixture of volatile organic compounds that we exhale. 99:59:59.999 --> 99:59:59.999 Now, this signature represents a fingerprint of your metabolism, 99:59:59.999 --> 99:59:59.999 your microbiome, 99:59:59.999 --> 99:59:59.999 and the biochemical processes that occur in your body. 99:59:59.999 --> 99:59:59.999 If you have a disease, 99:59:59.999 --> 99:59:59.999 your organisms will change, 99:59:59.999 --> 99:59:59.999 and so will the composition of your exhaled breath, 99:59:59.999 --> 99:59:59.999 and then the only thing that is left to do 99:59:59.999 --> 99:59:59.999 is to correlate a certain signature 99:59:59.999 --> 99:59:59.999 with the presence or absence of certain medical conditions. 99:59:59.999 --> 99:59:59.999 The technology promises several undeniable benefits. 99:59:59.999 --> 99:59:59.999 Firstly, the sensor can be miniaturized 99:59:59.999 --> 99:59:59.999 and integrated into small, handheld devices 99:59:59.999 --> 99:59:59.999 like this alcohol breath tester. 99:59:59.999 --> 99:59:59.999 This would allow the test to be used in many different settings 99:59:59.999 --> 99:59:59.999 and even at home, 99:59:59.999 --> 99:59:59.999 so that a visit at a doctor's office 99:59:59.999 --> 99:59:59.999 is not needed each time a test shall be performed. 99:59:59.999 --> 99:59:59.999 Secondly, breath analysis is non-invasive 99:59:59.999 --> 99:59:59.999 and can be as simple as blowing into an alcohol breath tester. 99:59:59.999 --> 99:59:59.999 Such simplicity and ease of use would reduce patient burden 99:59:59.999 --> 99:59:59.999 and provide an incentive for broad adoption of the technology. 99:59:59.999 --> 99:59:59.999 And thirdly, the technology is so flexible 99:59:59.999 --> 99:59:59.999 that the same device could be used 99:59:59.999 --> 99:59:59.999 to detect a broad range of medical conditions. 99:59:59.999 --> 99:59:59.999 Breath analysis could be used to screen for multiple diseases at the same time. 99:59:59.999 --> 99:59:59.999 Nowadays, each disease typically requires 99:59:59.999 --> 99:59:59.999 a different medical tool to perform a screening test, 99:59:59.999 --> 99:59:59.999 but this means you can only find what you're looking for. 99:59:59.999 --> 99:59:59.999 With all of these features, breath analysis is predestined 99:59:59.999 --> 99:59:59.999 to deliver what many traditional screening tests are lacking, 99:59:59.999 --> 99:59:59.999 and most importantly, all of these features 99:59:59.999 --> 99:59:59.999 should eventually provide us with a platform for medical analysis 99:59:59.999 --> 99:59:59.999 that can operate at attractively low cost per test. 99:59:59.999 --> 99:59:59.999 On the contrary, existing medical tools 99:59:59.999 --> 99:59:59.999 often lead to rather high cost per test. 99:59:59.999 --> 99:59:59.999 Then, in order to keep costs down, 99:59:59.999 --> 99:59:59.999 the number of tests needs to be restricted, 99:59:59.999 --> 99:59:59.999 and this means a) that the tests can only be performed 99:59:59.999 --> 99:59:59.999 on a narrow part of the population, for example the high-risk population, 99:59:59.999 --> 99:59:59.999 and b) that the number of tests per person needs to be kept at a minimum. 99:59:59.999 --> 99:59:59.999 But wouldn't it actually be beneficial 99:59:59.999 --> 99:59:59.999 if the test was performed on a larger group of people 99:59:59.999 --> 99:59:59.999 and more often and over a longer period of time for each individual? 99:59:59.999 --> 99:59:59.999 Especially the latter would give access to something very valuable 99:59:59.999 --> 99:59:59.999 that is called longitudinal data. 99:59:59.999 --> 99:59:59.999 Longitudinal data is a dataset that tracks the same patient 99:59:59.999 --> 99:59:59.999 over the course of many months or years. 99:59:59.999 --> 99:59:59.999 Nowadays, medical decisions 99:59:59.999 --> 99:59:59.999 are often based on a limited dataset 99:59:59.999 --> 99:59:59.999 where over a glimpse of a patient's medical history 99:59:59.999 --> 99:59:59.999 is available for decision-making. 99:59:59.999 --> 99:59:59.999 In such a case, 99:59:59.999 --> 99:59:59.999 abnormalities are typically detected 99:59:59.999 --> 99:59:59.999 by comparing a patient's health profile 99:59:59.999 --> 99:59:59.999 to the average health profile of a reference population. 99:59:59.999 --> 99:59:59.999 Longitudinal data would open up a new dimension 99:59:59.999 --> 99:59:59.999 and allow abnormalities to be detected 99:59:59.999 --> 99:59:59.999 based on a patient's own medical history. 99:59:59.999 --> 99:59:59.999 This will pave the way for personalized treatment. 99:59:59.999 --> 99:59:59.999 Sounds pretty great, right? 99:59:59.999 --> 99:59:59.999 Now you will certainly have a question 99:59:59.999 --> 99:59:59.999 that is something like, 99:59:59.999 --> 99:59:59.999 "If the technology is as great as he says, then why aren't they using it today?" 99:59:59.999 --> 99:59:59.999 And the only answer I can give you is, 99:59:59.999 --> 99:59:59.999 not everything is as easy as it sounds. 99:59:59.999 --> 99:59:59.999 There are technical challenges. 99:59:59.999 --> 99:59:59.999 For example, there's the need for extremely reliable sensors 99:59:59.999 --> 99:59:59.999 that can detect mixtures of volatile organic compounds 99:59:59.999 --> 99:59:59.999 with sufficient reproducibility. 99:59:59.999 --> 99:59:59.999 And another technical challenge is, 99:59:59.999 --> 99:59:59.999 how do you sample a person's breath in a very defined manner 99:59:59.999 --> 99:59:59.999 so that the sampling process itself 99:59:59.999 --> 99:59:59.999 does not alter the result of the analysis? 99:59:59.999 --> 99:59:59.999 And there's the need for data. 99:59:59.999 --> 99:59:59.999 Breath analysis needs to be validated in clinical trials, 99:59:59.999 --> 99:59:59.999 and enough data needs to be collected 99:59:59.999 --> 99:59:59.999 so that individual conditions 99:59:59.999 --> 99:59:59.999 can be measured against baselines. 99:59:59.999 --> 99:59:59.999 Breath analysis can only succeed 99:59:59.999 --> 99:59:59.999 if a large enough dataset can be generated 99:59:59.999 --> 99:59:59.999 and made available for broad use. 99:59:59.999 --> 99:59:59.999 If breath analysis holds up to its promises, 99:59:59.999 --> 99:59:59.999 this is a technology that could truly aid us 99:59:59.999 --> 99:59:59.999 to transform our health care system, 99:59:59.999 --> 99:59:59.999 transform it from a reactive system 99:59:59.999 --> 99:59:59.999 that treatment is triggered by symptoms of disease 99:59:59.999 --> 99:59:59.999 to a proactive system 99:59:59.999 --> 99:59:59.999 where disease detection, diagnosis and treatment 99:59:59.999 --> 99:59:59.999 can happen at early stage, 99:59:59.999 --> 99:59:59.999 way before any symptoms occur. 99:59:59.999 --> 99:59:59.999 Now this brings me to my last point, and it's a fundamental one. 99:59:59.999 --> 99:59:59.999 What exactly is a disease? 99:59:59.999 --> 99:59:59.999 Imagine that breath analysis can be commercialized as I describe it 99:59:59.999 --> 99:59:59.999 and early detection becomes routine. 99:59:59.999 --> 99:59:59.999 A problem that remains 99:59:59.999 --> 99:59:59.999 is in fact a problem that any screening activity has to face, 99:59:59.999 --> 99:59:59.999 because for many diseases, 99:59:59.999 --> 99:59:59.999 it is often impossible to predict with sufficient certainty 99:59:59.999 --> 99:59:59.999 whether the disease would ever cause any symptoms 99:59:59.999 --> 99:59:59.999 or put a person's life at risk. 99:59:59.999 --> 99:59:59.999 This is called overdiagnosis, 99:59:59.999 --> 99:59:59.999 and it leads to a dilemma. 99:59:59.999 --> 99:59:59.999 If a disease is identified, 99:59:59.999 --> 99:59:59.999 you could decide not to treat it 99:59:59.999 --> 99:59:59.999 because there's a certain probability that you would never suffer from it. 99:59:59.999 --> 99:59:59.999 But how much would you suffer 99:59:59.999 --> 99:59:59.999 just from knowing that you have a potentially deadly disease? 99:59:59.999 --> 99:59:59.999 And wouldn't you actually regret that the disease was detected in the first place? 99:59:59.999 --> 99:59:59.999 Your second option is to undergo early treatment 99:59:59.999 --> 99:59:59.999 with the hope for curing it, 99:59:59.999 --> 99:59:59.999 but often this would not come without side effects. 99:59:59.999 --> 99:59:59.999 To be precise, 99:59:59.999 --> 99:59:59.999 the bigger problem is not overdiagnosis, 99:59:59.999 --> 99:59:59.999 it's overtreatment, 99:59:59.999 --> 99:59:59.999 because not every disease has to be treated immediately 99:59:59.999 --> 99:59:59.999 just because a treatment is available. 99:59:59.999 --> 99:59:59.999 The increasing adoption of routine screening 99:59:59.999 --> 99:59:59.999 will raise the question: 99:59:59.999 --> 99:59:59.999 what do we call a disease that can rationalize treatment, 99:59:59.999 --> 99:59:59.999 and what is just an abnormality that should not be a source of concern? 99:59:59.999 --> 99:59:59.999 My hopes are that routine screening using breath analysis 99:59:59.999 --> 99:59:59.999 can provide enough data and insight 99:59:59.999 --> 99:59:59.999 so that at some point, we'll be able to break this dilemma 99:59:59.999 --> 99:59:59.999 and predict with sufficient certainty 99:59:59.999 --> 99:59:59.999 whether and when to treat at early stage. 99:59:59.999 --> 99:59:59.999 Our breath, and the mixture of volatile organic compounds 99:59:59.999 --> 99:59:59.999 that we exhale, 99:59:59.999 --> 99:59:59.999 hold tremendous amounts of information on our physiological condition. 99:59:59.999 --> 99:59:59.999 With what we know today, we have only scratched the surface. 99:59:59.999 --> 99:59:59.999 As we collect more and more data and breath profiles across the population, 99:59:59.999 --> 99:59:59.999 including all varieties of gender, age, origin and lifestyle, 99:59:59.999 --> 99:59:59.999 the power of breath analysis should increase, 99:59:59.999 --> 99:59:59.999 and eventually breath analysis should provide us with a powerful tool 99:59:59.999 --> 99:59:59.999 not only to proactively detect specific diseases 99:59:59.999 --> 99:59:59.999 but to predict and ultimately prevent them, 99:59:59.999 --> 99:59:59.999 and this should be enough motivation to embrace 99:59:59.999 --> 99:59:59.999 the opportunities and challenges 99:59:59.999 --> 99:59:59.999 that breath analysis can provide, 99:59:59.999 --> 99:59:59.999 even for people that are not part-time hypochondriacs like me. 99:59:59.999 --> 99:59:59.999 Thank you. 99:59:59.999 --> 99:59:59.999 (Applause)